• Bristol-Myers Squibb shares are experiencing downward pressure. Why is BMY stock retreating?
The U.S. ​Food and ‌Drug Administration on ​Friday ​approved Bristol Myers ⁠Squibb's ​combination ​treatment for adults and ​adolescents ​aged 12 and ‌older ⁠with previously untr
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Top Stock Picks of 2026: Bristol-Myers Squibb

09:39am, Friday, 20'th Mar 2026
For the final few weeks of the first quarter we're going to highlight one of Schaeffer's top 15 picks for 2026.
A death cross forms when a stock's 50-day moving average crosses below its 200-day moving average, signaling a potential downtrend.
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026.
U.S. President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his TrumpRx.gov website is not delivering across the board lower prices than those
Trinity Capital offers a 14% yield, trading at a discount with a diversified, largely secured portfolio and steady NII outpacing dividends. Bristol Myers Squibb is executing a portfolio transition, wi
After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on dividend stock investing.
Caerus Investment Advisors LLC acquired a new position in shares of Bristol Myers Squibb Company (NYSE: BMY) in the third quarter, according to its most recent disclosure with the Securities and Excha
Cim Investment Management Inc. cut its position in shares of Bristol Myers Squibb Company (NYSE: BMY) by 50.6% during the undefined quarter, according to its most recent disclosure with the Securities
Bristol Myers Squibb's stock has performed well so far this year, while the broader market has stumbled. Although the drugmaker faces a patent cliff, its growth portfolio makes up over half of total r
Achmea Investment Management B.V. grew its stake in shares of Bristol Myers Squibb Company (NYSE: BMY) by 16.2% in the undefined quarter, according to its most recent Form 13F filing with the Securiti
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The latest trading day saw Bristol Myers Squibb (BMY) settling at $59.71, representing a +1.07% change from its previous close.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE